Nuclear factor kappaB is required for the transcriptional control of type II NO synthase in regenerating liver.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1218734)

Published in Biochem J on September 15, 1997

Authors

M J Díaz-Guerra1, M Velasco, P Martín-Sanz, L Boscá

Author Affiliations

1: Instituto de Bioquímica (CSIC-UCM), Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61

Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 11.16

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell (1995) 7.13

Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem (1994) 6.91

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev (1993) 4.93

A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (1993) 4.65

Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med (1993) 4.06

I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell (1995) 3.95

Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell (1990) 3.58

Liver regeneration: molecular mechanisms of growth control. FASEB J (1990) 3.34

Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science (1995) 3.07

A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha 1-antitrypsin, albumin, and simian virus 40 genes. Proc Natl Acad Sci U S A (1988) 2.71

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J (1995) 2.64

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46

Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med (1994) 2.35

Inducible binding of a factor to the c-fos regulatory region. Proc Natl Acad Sci U S A (1987) 2.33

Liver regeneration 4: transcriptional control of liver regeneration. FASEB J (1996) 2.31

Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J (1994) 2.27

Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem (1995) 2.11

Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem (1993) 1.88

Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ (1995) 1.75

Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem (1994) 1.64

Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J (1996) 1.50

Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest (1993) 1.32

Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30

Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest (1995) 1.28

Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol (1991) 1.23

Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol (1993) 1.20

Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology (1995) 1.15

The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B. J Biol Chem (1995) 1.01

Glucose-dependent regulation of the L-pyruvate kinase gene in a hepatoma cell line is independent of insulin and cyclic AMP. FASEB J (1994) 0.99

Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology (1994) 0.97

Posttranscriptional regulation of gene expression in liver regeneration: role of mRNA stability. FASEB J (1996) 0.97

Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J Biol Chem (1996) 0.97

Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology (1995) 0.96

Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am J Physiol (1994) 0.95

Epr evidence of nitric oxide production by the regenerating rat liver. Biochem Biophys Res Commun (1994) 0.92

Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells. Biochem J (1992) 0.91

Articles by these authors

Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients. Aliment Pharmacol Ther (2011) 3.16

Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol (1998) 1.73

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Mortality among adult patients admitted to the hospital on weekends. Eur J Intern Med (2006) 1.67

Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J Exp Med (2001) 1.65

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis (2005) 1.43

[Knowledge and attitude regarding previous instructions for the patients of a public hospital of Madrid]. Rev Clin Esp (2011) 1.39

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol (2000) 1.39

Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. Hepatology (1996) 1.30

Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett (1997) 1.30

Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest (1995) 1.25

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2000) 1.22

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut (2004) 1.21

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem (2001) 1.17

Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology (2000) 1.14

Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (2000) 1.14

Modulation of muscle phosphofructokinase at physiological concentration of enzyme. J Biol Chem (1985) 1.13

Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects. Neuropharmacology (1981) 1.10

Regulation of rat liver S-adenosylmethionine synthetase during septic shock: role of nitric oxide. Hepatology (1997) 1.10

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Distribution of hepatitis B virus (HBV) markers in blood donors of 13 Western Hemisphere countries: proceedings of the Red Cross Latin American hepatitis B workshop. Bull Pan Am Health Organ (1980) 1.09

Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int J Tuberc Lung Dis (2006) 1.09

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J Clin Invest (1975) 1.07

Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am J Reprod Immunol (1994) 1.07

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

Bacterial lipopeptides induce nitric oxide synthase and promote apoptosis through nitric oxide-independent pathways in rat macrophages. J Biol Chem (1995) 1.05

Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab (1980) 1.05

Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages. FEBS Lett (1993) 1.05

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J (2001) 1.04

Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem (2000) 1.04

Rapid Up-regulation of IkappaBbeta and abrogation of NF-kappaB activity in peritoneal macrophages stimulated with lipopolysaccharide. J Biol Chem (1997) 1.01

Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med (2003) 1.01

Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J Biol Chem (1992) 1.00

Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages. FASEB J (1999) 1.00

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99

Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ (2010) 0.99

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat (1995) 0.99

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol (2000) 0.99

Up-regulation of protein kinase C-epsilon promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J Biol Chem (1996) 0.98

Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98

Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J Immunol (1999) 0.98

Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev (1996) 0.98

Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97

[Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population]. Rev Med Chil (1998) 0.97

Electrical stimulation of the centromedian thalamic nucleus in control of seizures: long-term studies. Epilepsia (1995) 0.97

Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J Biol Chem (1996) 0.97

Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology (1995) 0.96

Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. J Immunol (1998) 0.96

Anticonvulsant drugs and chromosomes. Lancet (1970) 0.96

Diabetes and hypertension physiopathology and therapeutics. J Hum Hypertens (2000) 0.95

Relationship between the displacement of phosphatidate phosphohydrolase from the membrane-associated compartment by chlorpromazine and the inhibition of the synthesis of triacylglycerol and phosphatidylcholine in rat hepatocytes. Biochim Biophys Acta (1986) 0.95

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2013) 0.95

Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95

Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology (2001) 0.94

Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis (2007) 0.94

Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci (1998) 0.94

Electrical stimulation for epilepsy: stimulation of hippocampal foci. Stereotact Funct Neurosurg (2001) 0.94

Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis. Gut (1968) 0.93

Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am J Physiol Gastrointest Liver Physiol (2000) 0.93

C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. Anticancer Res (1999) 0.93

Fructose 2,6-bisphosphate in isolated foetal hepatocytes. FEBS Lett (1987) 0.93

Subacute and chronic electrical stimulation of the hippocampus on intractable temporal lobe seizures: preliminary report. Arch Med Res (2000) 0.91

Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J Neurochem (2000) 0.91

Electrical stimulation of the prelemniscal radiation in the treatment of Parkinson's disease: an old target revised with new techniques. Neurosurgery (2001) 0.91

First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91

Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil. Clin Pharmacol Ther (1974) 0.91

Deep brain stimulation for treatment of the epilepsies: the centromedian thalamic target. Acta Neurochir Suppl (2007) 0.91

Hypertension and cardiovascular health in Venezuela and Latin American countries. J Hum Hypertens (2000) 0.91

A quantitative evaluation of the effects of L-dopa on Parkinson's disease. Neuropharmacology (1973) 0.90

Negative regulation by protein tyrosine phosphatase of IFN-gamma-dependent expression of inducible nitric oxide synthase. J Immunol (1999) 0.90

Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: Preliminary report. Transplant Proc (2006) 0.90

Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br J Pharmacol (1998) 0.90

Signal transduction pathways involved in B-cell induction. Immunol Rev (1993) 0.90

Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase. Biochem Biophys Res Commun (1982) 0.90

Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide. Hepatology (1993) 0.90

Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir Suppl (2007) 0.90

Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90

Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery (2000) 0.89

Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens (2002) 0.89

Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine. Clin Pharmacol Ther (1975) 0.89

Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Gastroenterology (2000) 0.89